Qiu Jin
The Key Laboratory Of Pathobiology, 126 Xinmin Avenue
Changchun, 130021, China
Changchun, 130021, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Correction: CLDN6 triggers NRF2-mediated ferroptosis through recruiting DLG1/PBK complex in breast cancer.
Journal: Cell death & disease
Published: August 21, 2025
CLDN6 induces chemoresistance through protective autophagy in breast cancer.
Journal: International journal of biological sciences
Published: April 24, 2025
CLDN6 triggers NRF2-mediated ferroptosis through recruiting DLG1/PBK complex in breast cancer.
Journal: Cell death & disease
Published: August 05, 2024
CLDN6 inhibits breast cancer growth and metastasis through SREBP1-mediated RAS palmitoylation.
Journal: Cellular & molecular biology letters
Published: February 04, 2024
CLDN6 inhibits colorectal cancer proliferation dependent on restraining p53 ubiquitination via ZO-1/PTEN axis.
Journal: Cellular signalling
Published: September 04, 2023
New insights into the regulation of METTL3 and its role in tumors.
Journal: Cell communication and signaling : CCS
Published: August 21, 2023
Independent prognostic value of CLDN6 in bladder cancer based on M2 macrophages related signature.
Journal: iScience
Published: August 09, 2023
CLDN6 inhibits breast cancer metastasis through WIP-dependent actin cytoskeleton-mediated autophagy.
CLDN6 inhibits breast cancer metastasis through WIP-dependent actin cytoskeleton-mediated autophagy.
Journal: Journal of experimental & clinical cancer research : CR
Published: January 11, 2023
CLDN6: From Traditional Barrier Function to Emerging Roles in Cancers.
Journal: International journal of molecular sciences
Published: November 15, 2021
CLDN6 Suppresses c-MYC-Mediated Aerobic Glycolysis to Inhibit Proliferation by TAZ in Breast Cancer.
CLDN6 Suppresses c-MYC-Mediated Aerobic Glycolysis to Inhibit Proliferation by TAZ in Breast Cancer.
Journal: International journal of molecular sciences
Published: November 14, 2021
CLDN6 inhibits breast cancer cell malignant behavior by suppressing ERK signaling.
Journal: Cellular signalling
Published: August 26, 2021
A SUMOylation-dependent HIF-1α/CLDN6 negative feedback mitigates hypoxia-induced breast cancer metastasis.
Journal: Journal of experimental & clinical cancer research : CR
Published: October 04, 2019
Showing 1-12 of 12
Last Updated: 09/26/2026